Jan is a senior partner in our Zurich office, where he specializes in the biopharmaceuticals and healthcare industries. He helps his clients develop corporate and business-unit strategies and serves leading companies in Switzerland, the broader Europe, Middle East, and Africa region, and also the United States, partnering with organizations to architect and deliver ambitious transformation programs in commercial, medical, R&D, and corporate functions.
Jan co-convenes the global strategy-and-corporate finance domain for the Life Sciences Practice. He also advises private-equity and principal investors on pre-investment decisions and post-investment management and leads McKinsey’s private-equity hub in Switzerland.
His areas of focus include innovation, portfolio strategies, and customer-engagement transformations in biopharma and commercial due diligence in life sciences and healthcare. Jan also supports end-to-end performance transformations in mid-sized companies, and effectiveness transformations in R&D functions, operations, and organizations.
Performance excellence is another sphere of interest for to him, particularly with how companies can drive executive performance and how considerations around well-being could help achieve this.
Jan received his MBA-equivalent degree from the WHU – Otto Beisheim School of Management in Germany and holds an master’s in finance from HEC Lausanne in Switzerland.
